AI assistant
Sending…
PROKIDNEY CORP. — Director's Dealing 2022
Sep 22, 2022
32485_dirs_2022-09-22_09fb3f98-71c7-4642-9024-0a72f69f302e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2022-09-20
Reporting Person: Fox Jennifer A. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-09-20 | Stock option (right to buy) | $9.73 | A | 129370 | Acquired | 2032-09-20 | Class A ordinary share (129370) | Direct |
Footnotes
F1: The shares underlying the option award vest in three equal annual installments beginning on July 11, 2023, subject to Ms. Fox's continued service as a director of the Company.
More from PROKIDNEY CORP.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 18
Regulatory Filings
2026
Mar 18
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3